4551 Torii Pharmaceutical
- 4250
- +135+3.28%
Torii Pharmaceutical News
Torii Pharmaceutical: Reference materials for financial results for the 3rd quarter of the fiscal year ending 2024/12
Torii Pharmaceutical: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
Torii Pharmaceutical: Confirmatory letter.
Torii Pharmaceutical: Semi-annual report - 133rd period (01/01/2024 - 12/31/2024)
Torii Pharmaceutical: Financial results announcement for the second quarter (interim period) of December 2024, based on Japanese accounting standards (non-consolidated).
Torii Pharmaceutical: Reference materials for the second quarter of the fiscal year ending December 2024.
Torii Pharmaceutical: Confirmation letter
Torii Pharmaceutical: Quarterly Report - 133rd Quarter (2024/01/01 to 2024/03/31)
Torii Pharmaceutical: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
Torii Pharmaceutical: Reference materials for the 1st quarter financial results for the fiscal year ending 2024/12
Torii Pharmaceutical: Extraordinary Report
Torii Pharmaceutical: Confirmation letter
Torii Pharmaceutical: Financial Report - 132nd Term (2023/01/01 - 2023/12/31)
Torii Pharmaceutical: Notice Concerning Dividends (Dividends Increase) from Surplus Funds
Torii Pharmaceutical: Financial results reference materials for the fiscal year ending 2023/12
Torii Pharmaceutical: Summary of financial results for the fiscal year ending 2023/12 [Japanese GAAP] (unconsolidated)
Torii Pharmaceutical: Confirmation letter
Torii Pharmaceutical: Quarterly Report - Period 132nd Third Quarter (2023/07/01 - 2023/09/30)
Torii Pharmaceutical: Summary of financial results for the 3rd quarter of the fiscal year ending December 31, 2023 [Japanese GAAP] (unconsolidated)
Torii Pharmaceutical: Reference materials for financial results for the 3rd quarter of the fiscal year ending 2023/12
Analysis
Price Target
No Data
No Data